zolpidem has been researched along with suvorexant in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 5 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Beuckmann, CT; Kazuta, Y; Kushida, I; Nakagawa, M; Naoe, Y; Ozaki, F; Suzuki, M; Takenaka, O; Terauchi, T; Ueno, T; Yonaga, M; Yoshida, Y | 1 |
| Abe, M; Aoki, T; Araki, Y; Futamura, A; Hattori, N; Kambe, D; Kawamoto, H; Nishikawa-Shimono, R; Nozawa, D; Ohmichi, M; Ohta, H; Ohtake, N; Suzuki, R; Tokura, S | 1 |
| Choi, Y; Raymer, BK | 1 |
| Herring, WJ; Lines, C; Ma, J; Roth, T; Snyder, E; Svetnik, V | 1 |
| Bondiskey, P; Cha, JH; Faulknor, J; Kennedy, WP; Levy-Cooperman, N; Lewis, NM; Li, X; Liu, W; McCrea, JB; Panebianco, DL; Schoedel, KA; Sellers, EM; Sun, H; Troyer, MD; Wagner, JA | 1 |
| Drexel, M; Gargano, C; Ma, J; Mayleben, D; Stoch, SA; Struyk, A; Svetnik, V | 1 |
| Hibino, H; Inoue, Y; Matsumoto, H; Mikami, A; Mikami, K; Suzuki, H | 1 |
| Herring, WJ; Lines, C; Roth, T; Scammell, TE; Snyder, ES; Svetnik, V; Tao, P | 1 |
| Nakao, M; Nishimura, S | 1 |
| Cardoso, R; Farah, B; Goodarzi, Z; Harricharan, S; Leech, J; Morin, CM; Morra, D; Nincic, V; Rios, P; Straus, SE; Tricco, AC | 1 |
| Earl, DC; Van Tyle, KM | 1 |
| Atkins, N; Citrome, L; Frech, F; Juday, T | 1 |
| Dingemanse, J; Kelsh, D; Schoedel, KA; Ufer, M | 1 |
| Allocca, G; Chu, J; Cornthwaite-Duncan, L; Daykin, H; Hoyer, D; Jacobson, LH; Keenan, RJ | 1 |
| Han, G; Imanishi, A; Kanbayashi, T; Nishino, S; Park, I; Satake, M; Shioya, T; Terui, Y; Uemura, SI | 1 |
3 review(s) available for zolpidem and suvorexant
| Article | Year |
|---|---|
Sleep modulating agents.
Topics: Animals; Humans; Sleep; Sleep Aids, Pharmaceutical; Sleep Wake Disorders; Wakefulness-Promoting Agents | 2019 |
Comparative effectiveness and safety of pharmacological and non-pharmacological interventions for insomnia: an overview of reviews.
Topics: Antidepressive Agents; Antipsychotic Agents; Azepines; Benzodiazepines; Cognitive Behavioral Therapy; Comparative Effectiveness Research; Humans; Hypnotics and Sedatives; Melatonin; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Systematic Reviews as Topic; Triazoles; Zolpidem | 2019 |
New pharmacologic agents for insomnia and hypersomnia.
Topics: Azepines; Carbamates; Dementia; Disorders of Excessive Somnolence; GABA-A Receptor Agonists; Humans; Orexin Receptor Antagonists; Phenylalanine; Piperidines; Pyridines; Pyrimidines; Sleep Aids, Pharmaceutical; Sleep Apnea, Obstructive; Sleep Initiation and Maintenance Disorders; Trazodone; Triazoles; Zolpidem | 2020 |
6 trial(s) available for zolpidem and suvorexant
| Article | Year |
|---|---|
Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects.
Topics: Adult; Aged; Azepines; Cross-Over Studies; Double-Blind Method; Electroencephalography; Female; Healthy Volunteers; Humans; Isoxazoles; Male; Middle Aged; Orexin Receptor Antagonists; Polysomnography; Pyridines; Sleep; Sleep Initiation and Maintenance Disorders; Triazoles; Young Adult; Zolpidem | 2014 |
Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.
Topics: Adult; Azepines; Cross-Over Studies; Double-Blind Method; Euphoria; Female; Hallucinations; Humans; Hypnotics and Sedatives; Illicit Drugs; Male; Middle Aged; Orexin Receptor Antagonists; Prescription Drug Misuse; Pyridines; Triazoles; Zolpidem | 2016 |
Insight Into Reduction of Wakefulness by Suvorexant in Patients With Insomnia: Analysis of Wake Bouts.
Topics: Aged; Azepines; Data Collection; Double-Blind Method; Female; Healthy Volunteers; Humans; Male; Orexin Receptor Antagonists; Placebos; Polysomnography; Problem Solving; Self Report; Sleep; Sleep Aids, Pharmaceutical; Sleep Initiation and Maintenance Disorders; Triazoles; Wakefulness; Zolpidem | 2018 |
Lemborexant for the Treatment of Insomnia: Direct and Indirect Comparisons With Other Hypnotics Using Number Needed to Treat, Number Needed to Harm, and Likelihood to Be Helped or Harmed.
Topics: Acetamides; Adolescent; Adult; Azepines; Benzodiazepines; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Orexin Receptor Antagonists; Pyridines; Pyrimidines; Sleep; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Triazoles; Young Adult; Zolpidem | 2021 |
Abuse potential assessment of the new dual orexin receptor antagonist daridorexant in recreational sedative drug users as compared to suvorexant and zolpidem.
Topics: Azepines; Cross-Over Studies; Double-Blind Method; Drug Users; Humans; Hypnotics and Sedatives; Imidazoles; Orexin Receptor Antagonists; Pyrrolidines; Triazoles; Zolpidem | 2022 |
Residual effects of low dose of suvorexant, zolpidem, and ramelteon in healthy elderly subjects: A randomized double-blind study.
Topics: Aged; Azepines; Double-Blind Method; Female; Humans; Hypnotics and Sedatives; Indenes; Male; Orexins; Triazoles; Zolpidem | 2022 |
6 other study(ies) available for zolpidem and suvorexant
| Article | Year |
|---|---|
Design, synthesis, and structure-activity relationships of a series of novel N-aryl-2-phenylcyclopropanecarboxamide that are potent and orally active orexin receptor antagonists.
Topics: Animals; Cyclopropanes; Drug Design; Humans; Male; Mice; Mice, Inbred C57BL; Models, Molecular; Orexin Receptor Antagonists; Orexin Receptors; Sleep; Sleep Initiation and Maintenance Disorders; Structure-Activity Relationship | 2014 |
Discovery and in vitro and in vivo profiles of N-ethyl-N-[2-[3-(5-fluoro-2-pyridinyl)-1H-pyrazol-1-yl]ethyl]-2-(2H-1,2,3-triazol-2-yl)-benzamide as a novel class of dual orexin receptor antagonist.
Topics: Animals; Benzamides; CHO Cells; Cricetulus; Dogs; Dose-Response Relationship, Drug; Drug Discovery; Humans; Male; Molecular Structure; Orexin Receptor Antagonists; Rats; Rats, Wistar; Structure-Activity Relationship; Triazoles | 2015 |
Pharmacodynamic effects of suvorexant and zolpidem on EEG during sleep in healthy subjects.
Topics: Adult; Aged; Azepines; Cross-Over Studies; Double-Blind Method; Electroencephalography; Healthy Volunteers; Humans; Hypnotics and Sedatives; Male; Middle Aged; Orexin Receptor Antagonists; Polysomnography; Pyridines; Sleep; Triazoles; Zolpidem | 2016 |
Benefits of switching to suvorexant for mild primary insomnia when sleepwalking episodes occur during zolpidem treatment.
Topics: Adult; Azepines; Female; GABA-A Receptor Agonists; Humans; Orexin Receptor Antagonists; Sleep Initiation and Maintenance Disorders; Somnambulism; Treatment Outcome; Triazoles; Zolpidem | 2017 |
Cost-effectiveness analysis of suvorexant for the treatment of Japanese elderly patients with chronic insomnia in a virtual cohort.
Topics: Aged; Aged, 80 and over; Azepines; Chronic Disease; Computer Simulation; Cost-Benefit Analysis; Female; Hip Fractures; Humans; Hypnotics and Sedatives; Japan; Male; Models, Econometric; Pyridines; Quality-Adjusted Life Years; Sleep Initiation and Maintenance Disorders; Triazoles; Zolpidem | 2018 |
Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathy.
Topics: Animals; Azepines; Disease Models, Animal; Female; Hypnotics and Sedatives; Male; Mice; Mice, Transgenic; Sex Characteristics; Sleep; Sleep Wake Disorders; Tauopathies; Triazoles; Zolpidem | 2022 |